Innomedica OÜ

At Innomedica OÜ in Tallinn, the clinical trial portfolio focuses on systemic lupus erythematosus and related immune system processes, with studies designed to better understand disease control and long-term treatment safety in adults with active autoimmune disease.

• Evaluating whether a new therapy can improve signs and symptoms of SLE compared with standard care or placebo
• Assessing the long-term safety of treatment for people living with moderately to severely active systemic lupus erythematosus
• Exploring how immune activity changes over time in autoimmune disease research

These studies help advance treatment options for complex inflammatory conditions and support better understanding of how to manage chronic rheumatologic disease.

The site also contributes to research in virus diseases, with a strong focus on influenza prevention in adults aged 50 years and older. This work examines whether different vaccine formulations produce consistent immune responses and adequate protection against seasonal influenza strains.

• Testing immune response consistency across multiple lots of an influenza vaccine
• Comparing antibody responses between vaccine formulations in older adults
• Supporting evaluation of vaccine effectiveness and immunogenicity in a higher-risk population

The research aims to strengthen confidence in influenza immunization by confirming that vaccines generate reliable immune protection in older adults and those with stable health conditions.